Immunohistochemical determination of HER-2/neu overexpression in malignant melanoma reveals no prognostic value, while c-Kit (CD117) overexpression exhibits potential therapeutic implications.

Anil Potti(Duke Medical Center), Michael O. Koch(Indiana University School of Medicine)
Journal of Carcinogenesis
January 1, 2003
Cited by 29


Related Papers